G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/29/2011	CA2803392A1 Dual variable domain immunoglobulins and uses thereof
12/29/2011	CA2803391A1 Colon and pancreas cancer specific antigens and antibodies
12/29/2011	CA2803027A1 Treatment of proliferative diseases
12/29/2011	CA2802919A1 Genetic markers associated with intellectual disability
12/29/2011	CA2802738A1 Chronic lymphocytic leukemia modeled in mouse by targeted mir-29 expression
12/29/2011	CA2802533A1 Methodology to determine feed quality (di+ring aromatic content) of fcc and hydrocracking feeds
12/29/2011	CA2802367A1 Method for adjusting concrete rheology based upon nominal dose-response profile
12/29/2011	CA2802065A1 Analysis of a microneutralization assay using curve-fitting constraints
12/29/2011	CA2801459A1 Lipidomic biomarkers for identification of high-risk coronary artery disease patients
12/29/2011	CA2801305A1 Detection of nucleic acids and proteins
12/29/2011	CA2798100A1 Novel jnk inhibitor molecules
12/28/2011	EP2400304A1 Method for the characterization of intermolecular interactions
12/28/2011	EP2400303A1 Markers of Oocyte quality
12/28/2011	EP2400302A1 Coagulogen raw material, process for producing same, and method and apparatus for measuring organism-derived biologically active substance using same
12/28/2011	EP2400301A1 Allergen detection method using immunochromatography
12/28/2011	EP2400300A1 Method of screening preventives/remedies for stress urinary incontinence
12/28/2011	EP2400299A1 Novel factors that promote triplet repeat expansions
12/28/2011	EP2400298A1 Single B-cell cultivation method and specific antibody production
12/28/2011	EP2400295A1 Evaluation peptide for use in quantification of protein using mass spectrometer, artificial standard protein, and method for quantifying protein
12/28/2011	EP2400294A1 Gas sensor and method of manufacturing the same
12/28/2011	EP2400293A1 Salinity measuring apparatus
12/28/2011	EP2400288A1 Non-invasive system for the determination of analytes in body fluids
12/28/2011	EP2400285A2 A Measuring Apparatus For Measuring A Physical Property Of A Sample
12/28/2011	EP2400036A1 Gene expression markers for colorectal cancer prognosis
12/28/2011	EP2400034A1 Diluent for preparing analytical sample
12/28/2011	EP2400033A1 Method for determining sensitivity of tumor cells to tyrosine kinase inhibitor and computer program product
12/28/2011	EP2400031A1 Method for measuring plasma glucose
12/28/2011	EP2400030A1 Detection of protein translocation by beta-galactosidase reporter fragment complementation
12/28/2011	EP2400029A2 Methods for cyclic nucleotide determination
12/28/2011	EP2400019A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400018A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400017A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400016A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400015A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400014A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400013A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400012A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400011A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400010A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400009A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400008A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400007A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400006A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400005A2 In tumours differentially expressed gene products and use of the same
12/28/2011	EP2400004A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400003A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400002A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400001A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2400000A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399999A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399998A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399997A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399996A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399995A2 In tumours differentially expressed gene products and use of the same.
12/28/2011	EP2399988A2 Cell culture system for replication of HCV through the farnesoid X receptor (FXR) activation or inhibition and diagnostic method for HCV infection
12/28/2011	EP2399937A1 Anti-human alpha9 integrin antibody and use thereof
12/28/2011	EP2399932A1 Compositions and methods for modulating immune responses
12/28/2011	EP2399927A1 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
12/28/2011	EP2399612A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system
12/28/2011	EP2399598A1 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer
12/28/2011	EP2399586A1 Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/28/2011	EP2399575A2 Methods, uses and compositions for treatment of an infection by a virus of the family of flaviviridae through the farnesoid X receptor (FXR) inhibition
12/28/2011	EP2399205A1 Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery
12/28/2011	EP2399136A2 Protein structural biomarkers to guide targeted chemotherapies
12/28/2011	EP2399135A2 Method for inhibiting neurodegeneration
12/28/2011	EP2399134A1 Gdf15 as molecular tool to monitor and enhance phenotypic stability of articular chondrocytes.
12/28/2011	EP2399133A1 Gdf15 as a differential marker for spondyloarthropathy
12/28/2011	EP2399132A1 Analysis method for the in vitro diagnosis of benign prostatic hyperplasia (bph) in dogs by assaying canine prostate specific esterase, and bph treatment follow up
12/28/2011	EP2399131A2 Method for the diagnosis of age-associated vascular disorders
12/28/2011	EP2399130A2 B7-h3 antibody coupled bead assay for isolation and detection of circulating tumor cells in body fluids of melanoma and breast cancer patients
12/28/2011	EP2399129A1 A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
12/28/2011	EP2399128A1 Diagnostic device
12/28/2011	EP2399127A2 Printing bio-reactive materials
12/28/2011	EP2399126A1 In situ testing of mechanical properties of cementitious material
12/28/2011	EP2399125A1 Apparatus and method for breath testing
12/28/2011	EP2399124A1 Measuring device and method for detecting the hydrocarbon fraction in gases
12/28/2011	EP2399121A1 An apparatus for the measurement of a concentration of a charged species in a sample
12/28/2011	EP2399120A1 Detecting a mineral within a material
12/28/2011	EP2399117A2 Directional surface plasmon coupled fluorescence and chemiluminescence from thin films of nickel, iron or palladium and uses thereof
12/28/2011	EP2399116A1 Sensing device for detecting a target substance
12/28/2011	EP2398922A2 Recql4/recql4 variant-p53 complex for altered mitochondrial function in rothmund-thomson syndrome
12/28/2011	EP2398919A2 Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles
12/28/2011	EP2398918A2 Compositions and methods for diagnosis and prognosis of colorectal cancer
12/28/2011	EP2398916A1 Regulatory nucleic acid of a human proteinase 3 variant
12/28/2011	EP2398912A1 Preservation of cell-free nucleic acids
12/28/2011	EP2398901A1 Jarid1b for target gene of cancer therapy and diagnosis
12/28/2011	EP2398868A1 Multiplex assay methods and compositions
12/28/2011	EP2398860A2 Quenched dendrimeric dyes for florescence detection
12/28/2011	EP2398828A2 Specific binding proteins and uses thereof
12/28/2011	EP2398816A1 Nucleic acids specifically binding with human factor vii/viia and uses thereof
12/28/2011	EP2398728A1 Programmable sensor suitable for controlling yarn feed to a textile machine and method for the programming thereof
12/28/2011	EP2398504A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value
12/28/2011	EP2398501A1 Use of vgii3 activity modulator for the modulation of adipogenesis
12/28/2011	EP2398481A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398480A1 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398479A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398388A2 Compact storage of auxiliary analytical devices in a cartridge
12/28/2011	EP2398385A1 Non-invasive biomedical detection and monitoring systems
12/28/2011	EP2398378A1 System and method for the electrochemical measurement of an analyte employing a remote sensor
12/28/2011	EP2385071A9 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1

1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 3937